Global Targeted Protein Degradation Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Targeted Protein Degradation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Oral
  • 1.2.3 Intravenous
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Targeted Protein Degradation Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospital
  • 1.3.3 Research Institute
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Targeted Protein Degradation Market Perspective (2016-2027)
• 2.2 Targeted Protein Degradation Growth Trends by Regions
  • 2.2.1 Targeted Protein Degradation Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Targeted Protein Degradation Historic Market Share by Regions (2016-2021)
  • 2.2.3 Targeted Protein Degradation Forecasted Market Size by Regions (2022-2027)
• 2.3 Targeted Protein Degradation Industry Dynamic
  • 2.3.1 Targeted Protein Degradation Market Trends
  • 2.3.2 Targeted Protein Degradation Market Drivers
  • 2.3.3 Targeted Protein Degradation Market Challenges
  • 2.3.4 Targeted Protein Degradation Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Targeted Protein Degradation Players by Revenue
  • 3.1.1 Global Top Targeted Protein Degradation Players by Revenue (2016-2021)
  • 3.1.2 Global Targeted Protein Degradation Revenue Market Share by Players (2016-2021)
• 3.2 Global Targeted Protein Degradation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Targeted Protein Degradation Revenue
• 3.4 Global Targeted Protein Degradation Market Concentration Ratio
  • 3.4.1 Global Targeted Protein Degradation Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Revenue in 2020
• 3.5 Targeted Protein Degradation Key Players Head office and Area Served
• 3.6 Key Players Targeted Protein Degradation Product Solution and Service
• 3.7 Date of Enter into Targeted Protein Degradation Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Protein Degradation Breakdown Data by Type

• 4.1 Global Targeted Protein Degradation Historic Market Size by Type (2016-2021)
• 4.2 Global Targeted Protein Degradation Forecasted Market Size by Type (2022-2027)

5 Targeted Protein Degradation Breakdown Data by Application

• 5.1 Global Targeted Protein Degradation Historic Market Size by Application (2016-2021)
• 5.2 Global Targeted Protein Degradation Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Targeted Protein Degradation Market Size (2016-2027)
• 6.2 North America Targeted Protein Degradation Market Size by Type
  • 6.2.1 North America Targeted Protein Degradation Market Size by Type (2016-2021)
  • 6.2.2 North America Targeted Protein Degradation Market Size by Type (2022-2027)
  • 6.2.3 North America Targeted Protein Degradation Market Size by Type (2016-2027)
• 6.3 North America Targeted Protein Degradation Market Size by Application
  • 6.3.1 North America Targeted Protein Degradation Market Size by Application (2016-2021)
  • 6.3.2 North America Targeted Protein Degradation Market Size by Application (2022-2027)
  • 6.3.3 North America Targeted Protein Degradation Market Size by Application (2016-2027)
• 6.4 North America Targeted Protein Degradation Market Size by Country
  • 6.4.1 North America Targeted Protein Degradation Market Size by Country (2016-2021)
  • 6.4.2 North America Targeted Protein Degradation Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Targeted Protein Degradation Market Size (2016-2027)
• 7.2 Europe Targeted Protein Degradation Market Size by Type
  • 7.2.1 Europe Targeted Protein Degradation Market Size by Type (2016-2021)
  • 7.2.2 Europe Targeted Protein Degradation Market Size by Type (2022-2027)
  • 7.2.3 Europe Targeted Protein Degradation Market Size by Type (2016-2027)
• 7.3 Europe Targeted Protein Degradation Market Size by Application
  • 7.3.1 Europe Targeted Protein Degradation Market Size by Application (2016-2021)
  • 7.3.2 Europe Targeted Protein Degradation Market Size by Application (2022-2027)
  • 7.3.3 Europe Targeted Protein Degradation Market Size by Application (2016-2027)
• 7.4 Europe Targeted Protein Degradation Market Size by Country
  • 7.4.1 Europe Targeted Protein Degradation Market Size by Country (2016-2021)
  • 7.4.2 Europe Targeted Protein Degradation Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Targeted Protein Degradation Market Size (2016-2027)
• 8.2 Asia-Pacific Targeted Protein Degradation Market Size by Type
  • 8.2.1 Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Targeted Protein Degradation Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Targeted Protein Degradation Market Size by Application
  • 8.3.1 Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Targeted Protein Degradation Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Targeted Protein Degradation Market Size by Region
  • 8.4.1 Asia-Pacific Targeted Protein Degradation Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Targeted Protein Degradation Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Targeted Protein Degradation Market Size (2016-2027)
• 9.2 Latin America Targeted Protein Degradation Market Size by Type
  • 9.2.1 Latin America Targeted Protein Degradation Market Size by Type (2016-2021)
  • 9.2.2 Latin America Targeted Protein Degradation Market Size by Type (2022-2027)
  • 9.2.3 Latin America Targeted Protein Degradation Market Size by Type (2016-2027)
• 9.3 Latin America Targeted Protein Degradation Market Size by Application
  • 9.3.1 Latin America Targeted Protein Degradation Market Size by Application (2016-2021)
  • 9.3.2 Latin America Targeted Protein Degradation Market Size by Application (2022-2027)
  • 9.3.3 Latin America Targeted Protein Degradation Market Size by Application (2016-2027)
• 9.4 Latin America Targeted Protein Degradation Market Size by Country
  • 9.4.1 Latin America Targeted Protein Degradation Market Size by Country (2016-2021)
  • 9.4.2 Latin America Targeted Protein Degradation Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Targeted Protein Degradation Market Size (2016-2027)
• 10.2 Middle East & Africa Targeted Protein Degradation Market Size by Type
  • 10.2.1 Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Targeted Protein Degradation Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Targeted Protein Degradation Market Size by Application
  • 10.3.1 Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Targeted Protein Degradation Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Targeted Protein Degradation Market Size by Country
  • 10.4.1 Middle East & Africa Targeted Protein Degradation Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Targeted Protein Degradation Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 5AM Venture Management LLC
  • 11.1.1 5AM Venture Management LLC Company Details
  • 11.1.2 5AM Venture Management LLC Business Overview
  • 11.1.3 5AM Venture Management LLC Targeted Protein Degradation Introduction
  • 11.1.4 5AM Venture Management LLC Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.1.5 5AM Venture Management LLC Recent Development
• 11.2 AbbVie Inc
  • 11.2.1 AbbVie Inc Company Details
  • 11.2.2 AbbVie Inc Business Overview
  • 11.2.3 AbbVie Inc Targeted Protein Degradation Introduction
  • 11.2.4 AbbVie Inc Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.2.5 AbbVie Inc Recent Development
• 11.3 Almac Group
  • 11.3.1 Almac Group Company Details
  • 11.3.2 Almac Group Business Overview
  • 11.3.3 Almac Group Targeted Protein Degradation Introduction
  • 11.3.4 Almac Group Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.3.5 Almac Group Recent Development
• 11.4 Amgen Inc.
  • 11.4.1 Amgen Inc. Company Details
  • 11.4.2 Amgen Inc. Business Overview
  • 11.4.3 Amgen Inc. Targeted Protein Degradation Introduction
  • 11.4.4 Amgen Inc. Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.4.5 Amgen Inc. Recent Development
• 11.5 Bayer AG
  • 11.5.1 Bayer AG Company Details
  • 11.5.2 Bayer AG Business Overview
  • 11.5.3 Bayer AG Targeted Protein Degradation Introduction
  • 11.5.4 Bayer AG Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.5.5 Bayer AG Recent Development
• 11.6 Biogen Inc.
  • 11.6.1 Biogen Inc. Company Details
  • 11.6.2 Biogen Inc. Business Overview
  • 11.6.3 Biogen Inc. Targeted Protein Degradation Introduction
  • 11.6.4 Biogen Inc. Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.6.5 Biogen Inc. Recent Development
• 11.7 C4 Therapeutics
  • 11.7.1 C4 Therapeutics Company Details
  • 11.7.2 C4 Therapeutics Business Overview
  • 11.7.3 C4 Therapeutics Targeted Protein Degradation Introduction
  • 11.7.4 C4 Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.7.5 C4 Therapeutics Recent Development
• 11.8 Cosmo Bio USA
  • 11.8.1 Cosmo Bio USA Company Details
  • 11.8.2 Cosmo Bio USA Business Overview
  • 11.8.3 Cosmo Bio USA Targeted Protein Degradation Introduction
  • 11.8.4 Cosmo Bio USA Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.8.5 Cosmo Bio USA Recent Development
• 11.9 Covance Inc
  • 11.9.1 Covance Inc Company Details
  • 11.9.2 Covance Inc Business Overview
  • 11.9.3 Covance Inc Targeted Protein Degradation Introduction
  • 11.9.4 Covance Inc Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.9.5 Covance Inc Recent Development
• 11.10 Eli Lilly and Company
  • 11.10.1 Eli Lilly and Company Company Details
  • 11.10.2 Eli Lilly and Company Business Overview
  • 11.10.3 Eli Lilly and Company Targeted Protein Degradation Introduction
  • 11.10.4 Eli Lilly and Company Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.10.5 Eli Lilly and Company Recent Development
• 11.11 Gilead Sciences, Inc
  • 11.11.1 Gilead Sciences, Inc Company Details
  • 11.11.2 Gilead Sciences, Inc Business Overview
  • 11.11.3 Gilead Sciences, Inc Targeted Protein Degradation Introduction
  • 11.11.4 Gilead Sciences, Inc Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.11.5 Gilead Sciences, Inc Recent Development
• 11.12 GlaxoSmithKline plc
  • 11.12.1 GlaxoSmithKline plc Company Details
  • 11.12.2 GlaxoSmithKline plc Business Overview
  • 11.12.3 GlaxoSmithKline plc Targeted Protein Degradation Introduction
  • 11.12.4 GlaxoSmithKline plc Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.12.5 GlaxoSmithKline plc Recent Development
• 11.13 Merck KGaA
  • 11.13.1 Merck KGaA Company Details
  • 11.13.2 Merck KGaA Business Overview
  • 11.13.3 Merck KGaA Targeted Protein Degradation Introduction
  • 11.13.4 Merck KGaA Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.13.5 Merck KGaA Recent Development
• 11.14 Mission Therapeutics
  • 11.14.1 Mission Therapeutics Company Details
  • 11.14.2 Mission Therapeutics Business Overview
  • 11.14.3 Mission Therapeutics Targeted Protein Degradation Introduction
  • 11.14.4 Mission Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.14.5 Mission Therapeutics Recent Development
• 11.15 Novartis AG
  • 11.15.1 Novartis AG Company Details
  • 11.15.2 Novartis AG Business Overview
  • 11.15.3 Novartis AG Targeted Protein Degradation Introduction
  • 11.15.4 Novartis AG Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.15.5 Novartis AG Recent Development
• 11.16 Pfizer Inc
  • 11.16.1 Pfizer Inc Company Details
  • 11.16.2 Pfizer Inc Business Overview
  • 11.16.3 Pfizer Inc Targeted Protein Degradation Introduction
  • 11.16.4 Pfizer Inc Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.16.5 Pfizer Inc Recent Development
• 11.17 Promega
  • 11.17.1 Promega Company Details
  • 11.17.2 Promega Business Overview
  • 11.17.3 Promega Targeted Protein Degradation Introduction
  • 11.17.4 Promega Revenue in Targeted Protein Degradation Business (2016-2021)
  • 11.17.5 Promega Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer